Vertex Pharmaceuticals Aktie

Kaufen
Verkaufen
384,60 EUR +6,35 EUR +1,68 %
405,12 USD +7,97 USD +2,01 %
Aktien, ETFs, Sparpläne & Kryptos zu Top-Konditionen beim Testsieger von finanztip.de handeln! Du hast schon ein ZERO-Konto? Direkt handeln bei ZERO! Bei einem anderen Broker handeln Smartphone

Marktkap. 100,42 Mrd. EUR

KGV 29,28 Div. Rendite 0,00%

WKN 882807

ISIN US92532F1003

Symbol VRTX


Vertex Pharmaceuticals Aktie Analyse

30.04.12 Vertex Pharmaceuticals overweight Barclays Capital
12.04.12 Vertex Pharmaceuticals overweight Barclays Capital
02.02.12 Vertex Pharmaceuticals overweight Barclays Capital
16.12.11 Vertex Pharmaceuticals outperform Credit Suisse Group
05.12.11 Vertex Pharmaceuticals buy Citigroup Corp.
22.11.11 Vertex Pharmaceuticals buy Citigroup Corp.
03.11.11 Vertex Pharmaceuticals outperform RBC Capital Markets
13.10.11 Vertex Pharmaceuticals outperform RBC Capital Markets
11.10.11 Vertex Pharmaceuticals buy Citigroup Corp.
06.10.11 Vertex Pharmaceuticals buy Citigroup Corp.
05.10.11 Vertex Pharmaceuticals buy Citigroup Corp.
04.10.11 Vertex Pharmaceuticals outperform RBC Capital Markets
07.09.11 Vertex Pharmaceuticals buy Citigroup Corp.
30.08.11 Vertex Pharmaceuticals buy Citigroup Corp.
18.08.11 Vertex Pharmaceuticals outperform William Blair
04.04.11 Vertex Pharmaceuticals outperform RBC Capital Markets
24.02.11 Vertex Pharmaceuticals overweight Piper Jaffray & Co.
24.02.11 Vertex Pharmaceuticals buy Goldman Sachs Group Inc.
08.02.11 Vertex Pharmaceuticals buy Goldman Sachs Group Inc.
22.12.10 Vertex Pharmaceuticals outperform RBC Capital Markets
27.05.10 Vertex Pharmaceuticals kaufen Needham & Company, LLC
23.04.10 Vertex Pharmaceuticals kaufen Needham & Company, LLC
05.02.10 Vertex Pharmaceuticals kaufen Morgan Stanley
04.12.09 Vertex Pharmaceuticals outperform Leerink Swann LLC
05.11.09 Vertex Pharmaceuticals overweight Morgan Stanley
05.05.09 Vertex Pharmaceuticals Global Biotech Investing
04.03.09 Vertex Pharmaceuticals outperform Credit Suisse Group
10.02.09 Vertex Pharmaceuticals outperform Credit Suisse Group
05.01.09 Vertex Pharmaceuticals buy Piper Jaffray & Co.
26.11.08 Vertex Pharmaceuticals outperform Credit Suisse Group
21.11.08 Vertex Pharmaceuticals buy Merriman Curhan Ford & Co
12.11.08 Vertex Pharmaceuticals buy Piper Jaffray & Co.
30.10.08 Vertex Pharmaceuticals buy Merriman Curhan Ford & Co
27.10.08 Vertex Pharmaceuticals positive Susquehanna Financial Group, LLLP
26.09.08 Vertex Pharmaceuticals buy Needham & Company, LLC
26.09.08 Vertex Pharmaceuticals market outperform JMP Securities LLC
22.08.08 Vertex Pharmaceuticals outperform Cowen and Company, LLC
09.07.08 Vertex Pharmaceuticals outperform Cowen and Company, LLC
10.06.08 Vertex Pharmaceuticals outperform Leerink Swann LLC
06.06.08 Vertex Pharmaceuticals positive Susquehanna Financial Group, LLLP
05.06.08 Vertex Pharmaceuticals outperform Leerink Swann LLC
22.05.08 Vertex Pharmaceuticals buy Pacific Growth Equities, LLC
29.04.08 Vertex Pharmaceuticals buy UBS AG
25.04.08 Vertex Pharmaceuticals outperform Leerink Swann LLC
11.04.08 Vertex Pharmaceuticals market outperform JMP Securities LLC
01.04.08 Vertex Pharmaceuticals outperform Robert W. Baird & Co. Incorporated
01.04.08 Vertex Pharmaceuticals positive Susquehanna Financial Group, LLLP
13.02.08 Vertex Pharmaceuticals buy UBS AG
29.01.08 Vertex Pharmaceuticals market outperform JMP Securities
24.01.08 Vertex Pharmaceuticals buy UBS AG